Polyp removed during Biden's colonoscopy is 'benign' -White House physician
Reuters
Published Nov 24, 2021 08:46PM ET
Updated Nov 24, 2021 09:25PM ET
WASHINGTON (Reuters) -A polyp removed during President Joe Biden's colonoscopy last week "is a benign, slow-growing, but thought to be precancerous lesion" for which no more action is required at this time, the White House physician said in a letter released on Wednesday.
The polyp was identified as a "tubular adenoma," which is similar to one Biden had removed in 2008, Dr. Kevin O'Connor said in the letter, which is dated Tuesday.
He said routine surveillance is recommended and that Biden should have another colonoscopy in seven to 10 years.
Biden briefly transferred power to Vice President Kamala Harris on Friday as he underwent the procedure, making her the first woman to hold the presidential reins in U.S. history.
In addition to the colonoscopy, Biden had a physical exam and O'Connor pronounced on Friday that the president was "healthy" and "vigorous" and fit for duty.
Biden, 79, is the oldest person to take office as U.S. president, leading to high interest in his health and well-being.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.